Medtronic presents positive data on TAVR, TMVR devices
Medtronic (NYSE:MDT) announced data from multiple trials supporting its transcatheter heart valve replacement devices.
Source: massdevice.com
Stay updated with breaking news from Corevalve Evolut Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic (NYSE:MDT) announced data from multiple trials supporting its transcatheter heart valve replacement devices.
Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets